Cervical cancer is rare & treatable if caught through screening. Anyone with a Cervix is at risk. This includes Cis Women with a cervix, including those with neo vaginas for vaginal Agenesis, Trans men, Non Binary people with a cervix, & Trans women. See pubmed.ncbi.nlm.nih.gov/28217933/
For Trans women with a neo vagina, talk to your (trans aware) healthcare provider to discuss whether screening &/or cervical screening is appropriate. Literature recommends annual pelvic examinations for pelvic cancer; & regular cytological smear testing for those with a cervix.
Its suggested that Trans women have regular mammography screening from age 50, especially when additional risk factors are present (Fierze et al, 2019). The same study recommends annual prostrate screening from the age of 45.
Today the Government has published a "Review of suicides and gender dysphoria at the Tavistock and Portman NHS Foundation Trust: independent report" by @ProfLAppleby. It is published in the context of a public discussion on suicide in relation to access to puberty blockers. 1/
This review is based upon two data sources: 1) Tavistock and Portman NHS Foundation Trust audit. 2) National Child Mortality Database (NCMD). It would be helpful for these sources to be published alongside the report in order that it be "open to independent scrutiny" 2/
The stated aim of the review is to "examine evidence for a large rise in suicides claimed by campaigners", & 5 summary conclusions are given. [In Screenshot with AltText].
In broad summary I do not disagree with the main message of points 1. 2. 3. and 5. 3/
Some important questions from @CatSmithMP here to the Department of Health. I look forward to @wesstreeting's responses. On Q262 (comparative assessment against other European countries) I can imagine he will refer to the Cass/ York's Systematic Review. However... 1/
As demonstrated by Yale Law School "Evidence-Based Critique of “The Cass Review” this failed to adhere to key components of a SR - "standardized and rigorous process that assesses quality of the entire body of evidence". York's paper on Clincal Guidelines is particulalry poor 2/
Yale correctly points out many faults by York's review on Guidelines, including that of 23 documents for analysis "8 were not guidelines at all. These documents were position papers & affirmative statements that explicitly deferred to actual guidelines" 3/adc.bmj.com/content/early/…
1. Puberty blockers have been used in Trans health since the 1980s the same as for precocious puberty. There is 40+ years evidence that this treatment is effective. With no recorded instances of serious harm. 2. Cass Review did not compare use of blockers in PP and Trans health.
The Cass Review provides no strong evidence that puberty blockers impact phychological and brain development. This is hypothesis and conjecture from a cis-supremacist position. Being Trans is not a bad outcome.
The NHS did not take a decision to ban puberty blockers. They were instructed to do so by Hilary Cass, who was in turn ordered to write a report by a government intent on removing Trans adolescent healthcare. There is no clinical Trial now. Lack of Trans healthcare is unsafe now!
In 1981 Stephen, a 14 yr old Trans boy in Pittsburg found a psychiatrist who would listen & asked for a 'sex change'. The psychiatrist spent 5 months analysing Stephen, & decided rather than provide hormone treatment he would prescribe anti depressents.. CW next tweet suicide 1/
Therapy' & antidepressents made things worse. Stephen had a number of suicide attempts immediately before or during menstruation. The psych to his credit, realised his treatment wasn't working & contacted an endocrinologist with experience working with 'Transsexuals' 2/
The Paediatric Endocrinologist, Dr Peter A Lee, prescribed medroxyprogesterone acetate, as a puberty blocker (now not used as less effective than GNrH agonists with a lot of side effects). Stephen had another period & took an overdose of amphetemines requiring intensive care 3/
Trans people have been using hormones for healthcare for around 100 years. There is 100 years of experience of Trans people helping each other source medication & use it as safely as possible working with health providers where possible in a 'least harm' approach. 1/
Under the current UK Government & NHS there is no access to adolescent healthcare. I believe there is a moral duty to help Trans youth who are accessing medication to do so as easily & as safely as possible. To highlight & mitigate the risks, & provide trusted information 2/
Further,, to enable Trans adolescents who may want access to Trans healthcare, to do so in line with International best practice & long established harm reduction guidelines. I will work with anyone with these aims & can provide resources, knowledge, platform & networks 3/
The question whether the Cass review team carried out engagement with Trans communities is immaterial. The engagement was not genuine, views shared in good faith by children & young people, families & support services were absent from synthesis & final recommendations. #CassFlaws
The methodology of the Cass Review qualitiative research stated they would conduct 40 interviews, 20 with 12-18s and 20 with adults up to age 30. They managed only 14 and 12 respectively. 26 interviews which were jumped on by gender critcal parents & anti Trans 'ex trans' groups
I'll repeat, in terms of the research output, the Cass York team conducted only 14 interviews with Trans children. 14 not even meeting the miniscule target set out in their research methodology.